PYY and obesity disorder: Conversely, ACSL5 knockdown reduces food intake by increasing glucagon-like peptide (GLP) and peptide YY (PYY) secretion and decreasing gastric emptying rate, mitigating HFD-induced obesity and insulin resistance [96].